Al-Azhar Cleft Lip and Palate Treatment Center, Faculty of Dental Medicine for Girls, Al-Azhar University, 1 Al Mokhaym Al Daem, Cairo, Egypt.
Al-Azhar Cleft Lip and Palate Treatment Center, Faculty of Dental Medicine for Girls, Al-Azhar University, 1 Al Mokhaym Al Daem, Cairo, Egypt; Department of Oro-dental Genetics, Center of Medical Excellence, National Research Centre, 33 El Buhouth St., Dokki, Cairo, Egypt; Stem Cell Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, 33 El Buhouth St., Dokki, Cairo, Egypt.
J Craniomaxillofac Surg. 2018 Sep;46(9):1593-1600. doi: 10.1016/j.jcms.2018.05.049. Epub 2018 Jun 2.
The aim of this study was to examine and assess the use of autologous bone marrow mononuclear cells (BMMNCs) combined with platelet-rich fibrin (PRF) and nanohydroxyapatite for bone regeneration as an effective technique for alveolar cleft repair.
This study included 20 patients with unilateral alveolar cleft defects and with an age range of 8-15 years. They were divided equally into two groups: Group A, received treatment via the regenerative approach which includes; autologous BMMNCs seeded on a collagen sponge in combination with nanohydroxyapatite and autologous PRF. Group B, received the standard alveolar bone grafting with iliac crest bone. The effectiveness of the new technique was evaluated and compared to the standard grafting technique through a 12-month follow-up via clinical and radiographic assessments.
During the 12-month follow-up, Group A exhibited less donor site complications, faster and better soft tissue healing, and less postoperative pain, when compared to group B. 90% of the cases in group A, exhibited complete alveolar bone union verses 70% only in group B.
Combination of BMMNCs, nanohydroxyapatite, and PRF greatly promote bone regeneration in alveolar cleft defects providing an alternative novel therapeutic strategy to the standard alveolar bone grafting.
本研究旨在探讨和评估自体骨髓单核细胞(BMMNC)联合富血小板纤维蛋白(PRF)和纳米羟基磷灰石在骨再生中的应用,作为牙槽裂修复的有效技术。
本研究纳入 20 例单侧牙槽裂缺损患者,年龄 8-15 岁。将其平均分为两组:A 组采用再生治疗方法,包括将自体 BMMNC 接种在胶原海绵上,与纳米羟基磷灰石和自体 PRF 结合;B 组采用髂嵴骨的标准牙槽骨移植。通过 12 个月的临床和影像学评估,对新技术的有效性进行评估和比较。
在 12 个月的随访期间,与 B 组相比,A 组患者的供区并发症较少,软组织愈合更快、更好,术后疼痛较轻。A 组 90%的病例表现出完全的牙槽骨融合,而 B 组只有 70%。
BMMNC、纳米羟基磷灰石和 PRF 的联合极大地促进了牙槽裂缺损中的骨再生,为标准牙槽骨移植提供了一种替代的新型治疗策略。